CD163 and diabetes mellitus: In conclusion, this study is the first to comprehensively characterize the RNA profile and phenotype of CD163+ monocytes in individuals with long-term diabetes and complications, presenting new implications for the role of CD163+ monocytes in diabetes-related complications.